Back to search
FDAFDA · Food and drugs·Recall number D-0480-2017

METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24

Published March 1, 2017 · Recall initiated: February 10, 2017

Summary

FDA records drug Class II recall D-0480-2017, published March 1, 2017 and initiated February 10, 2017. Recalling firm: Hospira Inc., A Pfizer Company; Status: Terminated; Reported quantity: 578,784 bags; Lot: Lot: 54-054-JT, 6/1/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance: customer report of leaking bag

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc., A Pfizer Company
Distributor
Nationwide and Puerto Rico
Lot
Lot: 54-054-JT, 6/1/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24 recalled?

Yes. FDA published recall D-0480-2017 on March 1, 2017. Reported hazard: Lack of Sterility Assurance: customer report of leaking bag

What should I do if I have this product?

Voluntary: Firm initiated · Letter